Paragon 28 To Report Third Quarter Financial Results on November 7, 2023
2023年10月18日 - 5:05AM
ビジネスワイヤ(英語)
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical
device company exclusively focused on the foot and ankle orthopedic
market, announced it will report financial results for the third
quarter 2023 after market close on Tuesday, November 7, 2023. The
company’s management will webcast a corresponding conference call
beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time.
Investors interested in listening to the conference call may do
so by dialing (833-470-1428) for domestic callers or (646-904-5544)
for international callers, using conference ID: 308457. Live audio
of the webcast will be available on the “Investors” section of the
company’s website at: ir.paragon28.com. The webcast will be
archived and available for replay for at least 90 days after the
event.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28, is a leading medical
device company exclusively focused on the foot and ankle orthopedic
market and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, forefoot,
ankle, progressive collapsing foot deformity (PCFD) or flatfoot,
charcot foot and orthobiologics. The company designs products with
both the patient and surgeon in mind, with the goal of improving
outcomes, reducing ailment recurrence and complication rates, and
making the procedures simpler, consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231017422378/en/
Investor Contact: Matthew Brinckman Senior Vice
President, Strategy and Investor Relations Phone: (720) 912-1332
mbrinckman@paragon28.com
Paragon 28 (NYSE:FNA)
過去 株価チャート
から 5 2024 まで 6 2024
Paragon 28 (NYSE:FNA)
過去 株価チャート
から 6 2023 まで 6 2024